Leonard Frank X
Chief Executive Officer
Leonard Frank X has filed 5 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jul 1, 2026.
On the most recent filing, Leonard Frank X is listed as Chief Executive Officer at NovoCure Ltd. Inside the rolling window, Leonard Frank X reported no open-market purchases and 4 open-market sales totaling $920K in NVCR. The largest disclosed transaction in the window is a sale of 34,273 NVCR shares on Jun 4, 2026, worth $615K.
Companies traded
Other insiders at NVCR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$920K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Leonard Frank X made?
Leonard Frank X has filed 5 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Leonard Frank X trade?
Leonard Frank X has filed SEC Form 4 disclosures for 1 company, including NVCR.
When was Leonard Frank X's most recent SEC Form 4 filing?
Leonard Frank X's most recent SEC Form 4 filing on Tracefour is dated Jul 1, 2026.
What is Leonard Frank X's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Leonard Frank X is listed as Chief Executive Officer.
What is Leonard Frank X's total buy and sell value in the current window?
Inside the rolling retention window, Leonard Frank X bought $0 and sold $920K based on SEC Form 4 filings.
What was Leonard Frank X's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 34,273 NVCR shares on 2026-06-04, worth $615K, per SEC Form 4 filings.